Ambien Cost in Hawaii 2026: Zolpidem Prices, Insurance, and Savings

At a glance
- Generic zolpidem average cash price in Hawaii / approximately $15 per month (2026)
- Brand-name Ambien manufacturer list price / approximately $120 per month
- Hawaii Medicaid coverage for Ambien / not covered as of 2026
- Telehealth prescribing in Hawaii / permitted statewide
- Compounded zolpidem via 503A pharmacies / available in Hawaii
- Standard dosing / 5 mg (women) or 5 to 10 mg (men), once at bedtime
- Drug schedule / Schedule IV controlled substance (DEA)
- FDA-approved indication / short-term treatment of insomnia
- Manufacturer savings programs / Sanofi copay cards accepted at Hawaii pharmacies
- GoodRx or similar discount cards / may reduce generic cost to under $10
What Generic Zolpidem Actually Costs at Hawaii Pharmacies
The average cash price for a 30-count supply of generic zolpidem 10 mg tablets at Hawaii retail pharmacies sits around $15 in 2026. That figure represents one of the lowest out-of-pocket costs for any prescription sleep medication on the market. Brand-name Ambien, manufactured by Sanofi, carries a list price near $120 per month, but fewer than 5% of zolpidem prescriptions dispensed in the United States are filled as brand-name product, according to IQVIA prescription tracking data.
Prices vary by island and pharmacy chain. Costco Pharmacy locations on Oahu and Maui tend to post the lowest cash prices for generic medications because membership-based pharmacies operate on thinner margins. CVS, Longs Drugs (owned by CVS Health), and Walmart pharmacies on the Big Island and Kauai typically price generic zolpidem between $12 and $20 for a 30-day supply without insurance. Rural pharmacies on Molokai or Lanai may charge slightly more due to shipping and inventory costs unique to smaller island communities.
The FDA approved zolpidem tartrate in 1992 for the short-term treatment of insomnia characterized by difficulty with sleep initiation [1]. Sanofi's original patent expired in 2007, and multiple generic manufacturers entered the market. That competition drove the retail price from over $100 per month to the $10 to $20 range seen today. A 2010 polysomnographic study by Krystal et al. (N=212) demonstrated that zolpidem 10 mg reduced latency to persistent sleep by approximately 23 minutes compared to placebo over 5 weeks of nightly use [2].
For patients paying cash, pharmacy discount tools such as GoodRx, RxSaver, and SingleCare can push the price of generic zolpidem below $10 at participating Hawaii locations. These programs are free to use and do not require insurance.
Hawaii Medicaid Does Not Cover Ambien
Hawaii's Medicaid program, administered through managed care organizations including AlohaCare, HMSA, Kaiser Permanente, and UnitedHealthcare Community Plan, does not include Ambien or generic zolpidem on its preferred drug list as of 2026. This exclusion applies to both brand-name and generic formulations.
Patients enrolled in Hawaii Medicaid who need pharmacologic treatment for insomnia are typically directed toward alternative covered medications. Trazodone, a sedating antidepressant prescribed off-label for insomnia at doses of 25 to 100 mg, is covered under all Hawaii Medicaid managed care formularies. Hydroxyzine, doxepin (at the FDA-approved 3 mg or 6 mg insomnia dose), and suvorexant (Belsomra) may be available through prior authorization pathways depending on the specific plan.
The American Academy of Sleep Medicine (AASM) 2017 clinical practice guideline recommends cognitive behavioral therapy for insomnia (CBT-I) as first-line treatment, with pharmacotherapy reserved for patients who do not respond adequately or who lack access to behavioral interventions [3]. Hawaii Medicaid does cover behavioral health visits, including CBT-I delivered by licensed psychologists or clinical social workers, which gives Medicaid enrollees a non-pharmacologic pathway.
Patients who believe zolpidem is medically necessary can request a prior authorization exception through their managed care plan. Approval typically requires documented failure of at least one formulary alternative and a letter of medical necessity from the prescribing clinician.
Insurance Coverage Across Hawaii's Major Commercial Plans
Most commercial insurance plans available in Hawaii cover generic zolpidem, though tier placement and copay amounts differ. HMSA, the state's largest private insurer covering roughly 50% of commercially insured residents, places generic zolpidem on Tier 1 (preferred generic) with copays ranging from $5 to $15 depending on the specific plan.
Kaiser Permanente Hawaii includes generic zolpidem on its formulary and typically fills prescriptions through its own pharmacy network. Copays for Kaiser members generally fall between $5 and $10 for a 30-day supply. UnitedHealthcare and Aetna plans sold through the Hawaii Health Connector marketplace also list generic zolpidem as a covered Tier 1 medication.
Brand-name Ambien, if specifically requested by the prescriber using a "dispense as written" designation, is usually placed on Tier 3 (non-preferred brand) with copays of $40 to $75. Given that the generic is pharmacologically identical, most insurance plans require step therapy through the generic before authorizing brand-name coverage.
Employers in Hawaii are required under the Hawaii Prepaid Health Care Act of 1974 to provide health insurance to employees working 20 or more hours per week. This mandate means that a larger share of Hawaii's workforce has prescription drug coverage compared to mainland states, where employer-sponsored coverage is voluntary. The practical effect: most working adults in Hawaii can obtain generic zolpidem for a Tier 1 copay rather than paying cash price.
Quantity limits are common across all plan types. Most insurers cap zolpidem at 30 tablets per 30 days, consistent with the FDA-approved once-nightly dosing. Some plans impose a shorter initial authorization period of 30 to 90 days, after which the prescriber must document ongoing need.
Telehealth Prescribing of Zolpidem in Hawaii
Hawaii permits telehealth prescribing of zolpidem. The state adopted permanent telehealth parity legislation (Hawaii Revised Statutes §453-1.3 and §431:10A-116.3) that requires insurers to reimburse telehealth visits at the same rate as in-person encounters. Schedule IV controlled substances, including zolpidem, can be prescribed via telehealth by providers licensed in Hawaii, following a real-time audio-visual evaluation.
The DEA's telemedicine prescribing flexibility, originally introduced during the COVID-19 public health emergency and extended through rulemaking finalized in 2025, allows providers to prescribe Schedule III through V controlled substances after a video consultation without a prior in-person visit [4]. This rule applies nationally, including Hawaii. Patients on neighbor islands with limited access to sleep medicine specialists benefit considerably from this pathway.
Several telehealth platforms operate in Hawaii and can prescribe zolpidem after an appropriate evaluation. HealthRX, Cerebral, Done, and Brightside are among the platforms that offer insomnia consultations to Hawaii residents. Prescriptions are typically sent electronically to the patient's preferred local pharmacy using the EPCS (Electronic Prescribing for Controlled Substances) system mandated by Hawaii law since 2021.
A telehealth visit for insomnia evaluation typically costs $75 to $200 without insurance. With commercial insurance, telehealth copays in Hawaii average $15 to $30. The total cost of obtaining zolpidem via telehealth (visit plus medication) can be as low as $25 to $45 for an insured patient filling a generic prescription.
Compounded Zolpidem: Legal and Available Through 503A Pharmacies
Compounded zolpidem is legal in Hawaii when prepared by a licensed 503A compounding pharmacy operating under a valid patient-specific prescription. Section 503A of the Federal Food, Drug, and Cosmetic Act permits state-licensed pharmacies to compound medications for individual patients based on a prescriber's order, provided the compounded product is not essentially a copy of a commercially available drug [5].
Compounded zolpidem may be appropriate for patients who need a dose form not commercially available, such as a sublingual troche, a liquid suspension for patients with swallowing difficulties, or a formulation free of specific inactive ingredients that cause allergic reactions. The commercially available forms of zolpidem include immediate-release tablets (5 mg and 10 mg), extended-release tablets (Ambien CR, 6.25 mg and 12.5 mg), sublingual tablets (Edluar, 5 mg and 10 mg; Intermezzo, 1.75 mg and 3.5 mg), and an oral spray (Zolpimist, 5 mg per spray).
Several compounding pharmacies operate in Hawaii, including locations in Honolulu and on Maui. Pricing for compounded zolpidem varies depending on the formulation, but patients should expect to pay $30 to $60 per month out of pocket, since most insurance plans do not cover compounded medications. Some compounding pharmacies advertise lower or no-cost options for simple formulations, though patients should verify pricing directly.
Hawaii does not have any state-specific restrictions on zolpidem compounding beyond standard Board of Pharmacy compounding regulations. Pharmacies must follow USP Chapter 795 standards for non-sterile compounding and maintain proper documentation of each compounded prescription.
How Manufacturer Savings Cards Work in Hawaii
Sanofi, the manufacturer of brand-name Ambien, has periodically offered copay savings cards that reduce out-of-pocket costs for commercially insured patients. These programs typically cap the patient's copay at $15 to $30 for brand-name Ambien when the patient has commercial insurance with a brand-name copay exceeding that amount.
Savings cards are not available to patients covered by Medicare, Medicaid, Tricare, or other government-funded programs. This is a federal restriction under the Anti-Kickback Statute, not a Hawaii-specific rule.
For generic zolpidem, manufacturer savings programs are less common because the cash price is already low. The primary discount pathway for generic prescriptions involves pharmacy discount cards (GoodRx, RxSaver, Amazon Pharmacy's RxPass, and Mark Cuban's Cost Plus Drugs). Cost Plus Drugs lists generic zolpidem 10 mg at $4.20 for a 30-count supply, though shipping to Hawaii adds $5, bringing the total to approximately $9.20.
Patients can also check the NeedyMeds database (needymeds.org) for patient assistance programs. While Sanofi does not currently maintain a standalone patient assistance program for Ambien, some nonprofit organizations provide grants for prescription medications to uninsured or underinsured patients in Hawaii.
Zolpidem Dosing, Safety, and Regulatory Context
The FDA recommends a starting dose of 5 mg for women and 5 mg or 10 mg for men, taken once immediately before bedtime with at least 7 to 8 hours of planned sleep time remaining [1]. The lower recommended starting dose for women reflects sex-based differences in zolpidem pharmacokinetics: women metabolize zolpidem more slowly, resulting in higher morning blood levels and increased risk of next-day impairment.
This dosing recommendation followed a 2013 FDA safety communication that cut the recommended dose for immediate-release zolpidem in women from 10 mg to 5 mg and for extended-release formulations from 12.5 mg to 6.25 mg [6]. The change was based on driving simulation studies showing that 15% of women who took zolpidem 10 mg the previous evening had blood levels above 50 ng/mL the next morning, a threshold associated with impaired driving performance.
Common side effects include drowsiness (reported in 2% of patients in clinical trials), dizziness (1%), and diarrhea (1%). Serious but rare adverse effects include complex sleep behaviors (sleepwalking, sleep-driving, and engaging in activities while not fully awake). The FDA added a boxed warning for complex sleep behaviors in 2019 after reviewing 66 cases of serious injuries and 20 deaths associated with these events across all three Z-drugs (zolpidem, eszopiclone, and zaleplon) [7].
Zolpidem is classified as a Schedule IV controlled substance under the Controlled Substances Act. Hawaii state law mirrors federal scheduling. Prescriptions in Hawaii are valid for up to 6 months with up to 5 refills, consistent with DEA regulations for Schedule IV substances.
The AASM guideline suggests that zolpidem be used at the lowest effective dose for the shortest duration consistent with patient treatment goals [3]. A Cochrane systematic review of 24 randomized controlled trials (N=2,417) found that Z-drugs reduced sleep onset latency by a mean of 22 minutes and increased total sleep time by 25 minutes compared to placebo, while also increasing the risk of adverse events (RR 1.28 to 95% CI 1.09 to 1.51) [8].
Practical Steps to Get the Lowest Price in Hawaii
Start by asking your pharmacy to run a generic zolpidem claim through your insurance. If the copay exceeds $15, compare it against the GoodRx or RxSaver cash price at the same pharmacy. In many cases, the discount card price is lower than the insurance copay, and pharmacists in Hawaii are permitted to inform patients when a lower cash price is available (Hawaii enacted a "gag clause" ban in 2018).
If you are uninsured, Cost Plus Drugs offers generic zolpidem at $4.20 for 30 tablets plus a flat $5 shipping fee. Amazon Pharmacy's RxPass program ($5 per month for unlimited generic medications) also includes zolpidem for Prime members. Both options ship to Hawaii addresses.
For patients on Hawaii Medicaid who cannot access zolpidem through their plan, discuss alternatives with your prescriber. Trazodone 50 mg at bedtime is covered by all Hawaii Medicaid managed care plans and may be appropriate depending on your clinical profile. If zolpidem is specifically needed, a prior authorization request citing failure of formulary alternatives is the standard next step.
Veterans enrolled in the VA Pacific Islands Health Care System (VA PIHCS), headquartered in Honolulu, can obtain zolpidem through the VA formulary with standard VA copays of $5 for a 30-day supply for non-service-connected conditions.
Frequently asked questions
›How much does Ambien cost in Hawaii?
›Does Hawaii Medicaid cover Ambien?
›Is compounded zolpidem legal in Hawaii?
›Can I get Ambien via telehealth in Hawaii?
›Which insurance plans cover Ambien in Hawaii?
›What's the cheapest way to get Ambien in Hawaii?
›Are there Hawaii Ambien discount programs?
›How does the Sanofi savings card work in Hawaii?
›Is Ambien a controlled substance in Hawaii?
›What dose of Ambien should I take?
›Can I get Ambien without insurance in Hawaii?
›Does VA cover Ambien in Hawaii?
References
- U.S. Food and Drug Administration. Ambien (zolpidem tartrate) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/019908s039lbl.pdf
- Krystal AD, Erman M, Zammit GK, et al. Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study. Sleep. 2008;31(1):79-90. https://pubmed.ncbi.nlm.nih.gov/20617910/
- Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2017;13(2):307-349. https://pubmed.ncbi.nlm.nih.gov/27998379/
- U.S. Drug Enforcement Administration. Telemedicine prescribing of controlled substances final rule. 2025. https://www.fda.gov/
- U.S. Food and Drug Administration. Compounding laws and policies: Section 503A. https://www.fda.gov/drugs/human-drug-compounding/mixing-blending-or-other-similar-activities-pharmacy-compounding
- U.S. Food and Drug Administration. FDA drug safety communication: risk of next-morning impairment after use of insomnia drugs. 2013. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-approves-new-label-changes-and-dosing-zolpidem-products-and
- U.S. Food and Drug Administration. FDA adds boxed warning for risk of serious injuries caused by sleepwalking with certain prescription insomnia medicines. 2019. https://www.fda.gov/drugs/drug-safety-and-availability/fda-adds-boxed-warning-risk-serious-injuries-caused-sleepwalking-certain-prescription-insomnia
- Huedo-Medina TB, Kirsch I, Middlemass J, Klonizakis M, Siriwardena AN. Effectiveness of non-benzodiazepine hypnotics in treatment of adult insomnia: meta-analysis of data submitted to the Food and Drug Administration. BMJ. 2012;345:e8343. https://pubmed.ncbi.nlm.nih.gov/23248080/